{"id":"tp-54305","type":"article-newspaper","title":"Liquidia Sets 2028 PH-ILD Goal, 2029 L606 NDA Submission Target","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54305","datePublished":"2026-11-11T18:12:57.000Z","dateModified":"2026-11-11T18:12:57.000Z","language":"en","abstract":"Liquidia Corporation plans to complete PH-ILD enrollment in 2028 and has a 2029 target for an L606 new drug application submission.","section":"Business","references":[]}